Dr Fox for Merrion Pharmaceuticals

Merrion Pharmaceuticals has appointed of Dr John Fox as chief development officer.

Dr Fox will be responsible for Merrion’s Dublin-based development operations.

Dr Fox has over 20 years of experience in the pharmaceutical industry, and joins Merrion from Hunter Fleming where, as chief operating officer, he was chiefly responsible for pharmaceutical development of new medicines, regulatory compliance, valuations, portfolio planning and IP maintenance.

He also held clinical research and development roles in Eli Lilly & Co.